Aksilla makrometastazlarında sentinel lenf nodu biyopsisi yeterli mi?

References (9)

1. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blu- mencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011
2. [CrossRef] Giuliano AE, Morrow M, Ballman KV. Axillary vs sentinel lymph node dissection for invasive breast cancer. JAMA 2011
3. [CrossRef] Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomi- sed controlled trial. Lancet Oncol 2013
4. [CrossRef] Fayda M, Karanlik H. Axillary versus sentinel-lymph-node dissec- tion for micrometastatic breast cancer. Lancet Oncol 2013
5. e250. [CrossRef] Harbeck N, Thomssen C, Gnant M. St. Gallen 2013: Brief prelimi- nary summary of the consensus discussion. Breast Care (Basel) 2013
6. [CrossRef] Jagsi R, Chadha M, Moni J, Ballman K, Laurie F, Buchholz TA, et al. Radiation field design in the ACOSOG Z0011 (Alliance) Trial. J Clin Oncol 2014
7. [CrossRef] Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non- inferiority trial. Lancet Oncol 2014
8. [CrossRef] Gooch J, King TA, Eaton A, Dengel L, Stempel M, Corben AD, et al. The extent of extracapsular extension may influence the need for axillary lymph node dissection in patients with T1-T2 breast cancer. Ann Surg Oncol 2014
9. [CrossRef] 255